Moreover, peptides in GLP-1 drugs are derived from living cells through recombinant DNA technology, which makes their manufacturing process more complex and expensive than traditional pills
Many commercial programs focus only on calorie restriction
Key Structural Differences# Head-to-Head: LEAD-6 Trial# The LEAD-6 trial (Buse et al., Lancet 2009) directly compared liraglutide 1.8 mg once daily with exenatide 10 mcg twice daily in 464 adults with type 2 diabetes inadequately controlled on metformin, sulfonylurea, or both over 26 weeks: Liraglutide was statistically superior for glycemic control and demonstrated better tolerability, with less persistent nausea and fewer hypoglycemia events
Interestingly, metabolomic analysis in this study indicated that semaglutide treatment upregulated L-isoleucine and methacholine or downregulated L-histidinol, arachidonic acid, and 4,5- leukotriene (LT) A4 LysoPC(16:0), which are metabolites involved in the pathogenesis of NAFLD [32]
Adverse Events Of the 15 trials, four did not report adverse event (AE) data